Investment Rating - The report maintains a positive outlook on the cosmetics and medical beauty sector, with specific recommendations for companies like Maogeping and Shangmei Co. [4][9] Core Insights - The cosmetics and medical beauty sector underperformed the market during the reporting period, with the Shenwan Beauty Care Index declining by 3.1% [5] - The upcoming Double 11 shopping festival is expected to boost sales for Shangmei Co. and Maogeping, with strong performance anticipated on platforms like Douyin and Tmall [4][9] - Key companies such as Proya and Shanghai Jahwa reported mixed results, with Proya's revenue for Q3 2025 at 1.736 billion yuan, down 11.63% year-on-year, while Shanghai Jahwa's revenue grew by 28% to 1.483 billion yuan [10][15] Summary by Sections Industry Performance - The cosmetics and medical beauty sector showed a decline, with the Shenwan Cosmetics Index down 2.6% and the Shenwan Personal Care Index down 0.9% [5] - The top-performing stocks included *ST Meigu (+12.3%) and Jinsong New Materials (+6.2%), while Huaxi Biological and Beitaini saw declines of 7.8% and 7.4%, respectively [5] Company Performance - Proya's Q3 2025 revenue was 1.736 billion yuan, a decrease of 11.63% year-on-year, with a net profit of 227 million yuan, down 23.64% [10] - Shanghai Jahwa reported Q3 revenue of 1.483 billion yuan, an increase of 28%, with a net profit of 140 million yuan [15] - Ruoyuchen's Q3 revenue reached 819 million yuan, up 123.4% year-on-year, with a net profit of 33 million yuan [18] Market Trends - The 8th China International Import Expo showcased major international beauty brands, highlighting trends such as high-end market targeting and AI technology in beauty research and development [27] - The report indicates that the Chinese market is evolving into a global innovation hub for beauty products, with a focus on sustainability and green transformation [27] E-commerce Insights - The report provides data on the performance of domestic brands on platforms like Douyin and Tmall, with Shangmei Co. achieving significant growth in GMV [21] - The overall retail sales of cosmetics in September 2025 grew by 8.6%, driven by pre-Double 11 promotions [22][24]

Core Viewpoint - Shanghai Jahwa reported a significant improvement in financial performance for the first three quarters of 2025, with total revenue reaching 4.961 billion yuan, a year-on-year increase of 11%, and a net profit of 405 million yuan, up 149% compared to the previous year [1] Financial Performance - The company's gross margin increased by 7 percentage points to 61.48%, attributed to product structure optimization and changes in raw material procurement prices [2] - The net profit margin rose by 16 percentage points to 9.41%, driven by improved gross margins and increased income from investment funds and joint ventures [2] - The company implemented strategic adjustments in 2024 due to industry downturns, which have led to a steady recovery in overall performance in 2025 [2] Business Segments - Revenue from personal care, beauty, innovation, and overseas businesses in Q3 2025 grew by 14%, 272%, 5%, and decreased by 3% respectively, totaling 606 million, 354 million, 158 million, and 365 million yuan [3] - Online sales in domestic markets increased by 173%, benefiting from a low revenue base from the previous year due to strategic adjustments [3] - The company experienced volume and price increases in personal care and beauty segments, with sales volume up by 9% and 101%, and average prices up by 5% and 85% respectively [3] Brand Strategy - The company focused on developing major products and enhancing brand building, with successful new product launches and marketing efforts [4] - Key products include the second-generation mosquito repellent from Six God, which contributed to customer growth, and the launch of a new fragrance shower gel [4] - The brand "Bai Cao Ji" achieved significant market presence with its new herbal skincare product, while "Yu Ze" and "Gao Fu" targeted specific demographics with strategic endorsements [4] Profit Forecast - The company is expected to continue its strategic adjustments, with projected EPS for 2025-2027 at 0.62, 0.76, and 0.91 yuan, corresponding to PE ratios of 41, 33, and 28 times at the current stock price [5]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company reported a revenue increase of 28.3% year-on-year for Q3 2025, with significant improvements in profitability due to strategic adjustments [1] - The beauty and personal care segments showed high growth, with online sales increasing by 173.3% year-on-year in Q3 2025 [1] - The gross profit margin improved significantly, with a year-on-year increase of 7.0 percentage points in Q3 2025 [1] - The company has successfully launched new products that have performed well in the market, contributing to its revenue growth [1] - The earnings forecast has been revised upwards for 2025-2027, reflecting the company's strong performance and effective reforms [1] Financial Summary - Total revenue for 2023 is projected at 6,598 million yuan, with a forecasted increase to 7,688 million yuan by 2027 [1][8] - The net profit attributable to shareholders is expected to recover from a loss of 833.09 million yuan in 2024 to a profit of 603.20 million yuan by 2027 [1][8] - The latest diluted EPS is projected to improve from -1.24 yuan in 2024 to 0.90 yuan in 2027 [1][8] - The company’s P/E ratio is expected to decrease from 44.62 in 2025 to 30.49 in 2027, indicating a potential increase in valuation [1][8]